Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Nova Eye Medical Limited (ASX: EYE) is a global medical technology company dedicated to developing and commercializing a portfolio of innovative ophthalmic treatment technologies and devices. With a strong focus on glaucoma, the company's flagship products include the iTrack™ Advance minimally invasive glaucoma surgery (MIGS) system and the Molteno3® glaucoma drainage devices. These advanced solutions are utilized by eye surgeons in over 100 countries, aiming to improve patient outcomes and alleviate the worldwide burden of glaucoma by offering less invasive and more effective treatment options.
The Adelaide headquarters serves as the central hub for corporate management, research and development, global strategy, financial control, and administrative operations for Nova Eye Medical.
Located in Adelaide's central business district, the office provides a modern and collaborative environment. Specific architectural highlights are not publicly detailed, but its location supports accessibility and engagement with the local business and research community.
The work culture at Nova Eye Medical's HQ emphasizes innovation, precision, collaboration, and a patient-centric approach. Employees are driven by the impact of their work on individuals suffering from glaucoma worldwide and are committed to advancing ophthalmic care.
The Adelaide HQ is significant as it anchors the company's global operations, leads its research and development efforts in ophthalmic technology, and represents its Australian origins and listing on the Australian Securities Exchange (ASX).
Nova Eye Medical maintains a significant global presence, anchored by its corporate headquarters in Adelaide, Australia, and strategically positioned regional offices in Fremont, California (USA), and Eschborn, Germany (Europe). These hubs support a broad network for sales, marketing, clinical training, and distribution, enabling their proprietary ophthalmic technologies to reach eye surgeons and patients in over 100 countries worldwide.
100 Pirie Street
Adelaide
South Australia
Australia
Address: 41350 Christy Street, Fremont, CA 94538, USA
To drive the adoption, sales, and comprehensive support for iTrack™ and Molteno3® products within the United States and Canada, engaging directly with ophthalmic surgeons, clinics, and healthcare providers.
Address: Ludwig-Erhard-Str. 30-34, 65760 Eschborn, Germany
To expand market presence, manage distribution channels, and provide localized technical and clinical support for Nova Eye Medical's glaucoma treatment technologies throughout Europe and potentially other EMEA regions.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Nova Eye Medical' leadership includes:
Nova Eye Medical has been backed by several prominent investors over the years, including:
Over the past 12 months, Nova Eye Medical experienced a key transition in its finance leadership with the resignation of its Chief Financial Officer and the subsequent appointment of a new CFO.
Discover the tools Nova Eye Medical uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Nova Eye Medical commonly uses an email format that combines an employee's first initial with their full last name, followed by '@nova-eye.com'. This is a standard professional email structure.
flast@nova-eye.com
Format
tspurling@nova-eye.com
Example
85%
Success rate
Nova Eye Medical ASX Announcements • March 27, 2024
Nova Eye Medical announced an update on its FDA Investigational Device Exemption (IDE) pivotal study for the iTrack™ Advance. The company reported successful completion of patient recruitment for the study, a key milestone towards FDA submission for the next-generation device in the US market....more
Nova Eye Medical ASX Announcements • February 22, 2024
Nova Eye Medical reported its financial results for the first half of FY24, highlighting sales growth driven by its iTrack portfolio and expanded global market penetration. The company emphasized ongoing investment in R&D and clinical studies for future product enhancements....more
Nova Eye Medical ASX Announcements • August 28, 2023
Nova Eye Medical announced the appointment of Ms. Kate Hunt as its new Chief Financial Officer, effective September 11, 2023. Ms. Hunt brings significant experience in financial management and strategy within listed companies and the healthcare sector....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Nova Eye Medical, are just a search away.